# Octapharma AB – FDA Inspection, Jan 20, 2011

Source: https://www.keypedia.com/records/fda_inspections/octapharma-ab/e46fa3b2-794a-456e-97d5-2b973b8e1194
Source feed: FDA_Inspections

> FDA inspection 710676 of Octapharma AB, January 20, 2011. Classification: Official Action Indicated (OAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 710676
- Company Name: Octapharma AB
- Inspection Date: 2011-01-20
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1218250 - 2023-09-19](https://www.keypedia.com/records/fda_inspections/octapharma-ab/3645f477-d675-40fc-90b8-3704a595408d)
- [FDA Inspection 1070173 - 2018-09-28](https://www.keypedia.com/records/fda_inspections/octapharma-ab/d1bd9bce-fbba-4979-be9f-74a49e7eed87)
- [FDA Inspection 994537 - 2016-10-03](https://www.keypedia.com/records/fda_inspections/octapharma-ab/6b3e378f-099f-4e8b-a570-ba2acbf16cb8)
- FDA Inspection 894095 - 2014-04-28
- FDA Inspection 783783 - 2012-01-19

Company: https://www.keypedia.com/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
